TJ Ademiluyi and Adun Akanni, Alaffia Health Co-Founders

“Most insurance payers ideally would like to review more of their claims, but with claim volumes in the millions, it’s currently impossible to do so–industry incumbents are still reviewing medical claims and records by hand,” says TJ Ademiluyi, co-founder and CEO of Alaffia Health.

NEW YORK (PRWEB)
February 09, 2022

Alaffia Health, a cutting-edge healthtech company that is using proprietary AI technology to eliminate overpayments on medical claims, announced today that it has raised $5M in Seed funding, bringing its total amount of capital raised to $6.6M. The company intends to both scale its operations and expand its commercial footprint. The round was led by Anthemis with participation from investors including 1984 Ventures, Aperture Venture Capital, Tau Ventures, Twine Ventures, Plug and Play Ventures, ERA’s Remarkable Ventures Fund, and a group of other best-in-class investors and healthcare leaders.

Alaffia Health was founded in 2020 by TJ Ademiluyi and Adun Akanni, a brother and sister founding team who are using knowledge obtained from their family’s legacy medical billing business to reduce costs and waste in the healthcare system. Today, healthcare expenditures comprise about 1/5th of the U.S. GDP, and a significant portion of that spending is derived from errors in health insurance claims. It is estimated that about 80% of claims in the US contain at least one medical billing error, and $300B is lost to provider fraud, waste, and abuse every year.

Alaffia Health is working to lower healthcare costs by disrupting how and when medical claims are paid. The company offers health insurance payers (health plans, third-party administrators, self-insured employers, and stop-loss carriers) an AI-driven payment integrity service, working alongside them to review claims more thoroughly and in less time. “The issue with the industry status quo is that most medical claims aren’t fully reviewed but are paid automatically,” said Adun Akanni, co-founder and COO of Alaffia Health. “It’s likely that while maybe only half of the charges in that $10,000 bill sent to your health insurance payer were legitimate, a full payment was automatically granted. Given that 80% of medical claims contain an error, that wasted spend adds up quickly.”

Alaffia Health is redefining how claims are processed. It has introduced a more proactive system–thoroughly reviewing claims and supporting documentation on a prepayment basis to ensure that more claims are paid accurately. “Most insurance payers ideally would like to review more of their claims, but with claim volumes in the millions, it’s currently impossible to do so–industry incumbents are still reviewing medical claims and records by hand,” says TJ Ademiluyi, co-founder and CEO of Alaffia Health. The company is leveraging artificial intelligence to tackle this problem and automate the most arduous tasks. Its proprietary system allows each charge and piece of supporting documentation in higher-cost claims to be reviewed 5x faster than industry standards. This allows its customers to increase both the volume and integrity of claims that are reviewed.

Since its founding, the company has grown rapidly, scaling the size of its team by 5x and increasing its revenues by 24x in 2021 alone. Alaffia plans to use its new funding to expand its operations and further penetrate its target markets. Vinay Singh from Anthemis noted, “COVID-19 has brought added focus from all industry participants–providers, payers, and regulators–on overpayments and waste throughout the healthcare system. Alaffia Health’s technology offers a seamless, efficient solution that has an immediate impact on reducing that waste.”

——-

About Alaffia Health

Alaffia Health is a healthtech company that uses machine learning and AI to proactively eliminate provider fraud, waste, and abuse in healthcare claims. The company offers an AI-driven payment integrity service to healthcare payers such as health plans, third-party administrators, self-insured employers, stop-loss carriers, and government agencies to eliminate overpayments and reduce healthcare costs.

About Anthemis

Anthemis is a global investment platform that cultivates change in our financial system by investing in, growing, and sustaining businesses committed to resiliency, transparency, access and equity. Founded on three guiding principles–authentic collaboration, virtuous cycle outcomes and diversity and inclusivity–our deep understanding of markets and models, passion for emerging technology and values inspire everything we do. By creating fertile ground for a diverse group of startups, investors, entrepreneurs, institutions, academics, and visionaries to converge, we believe we can solve the financial systems most pressing challenges faster, better and for the benefit of all.

Share article on social media or email:

Dr. Humza Ilyas of Olansky Dermatology & Aesthetics recently received the prestigious honor of becoming board certified for Mohs surgery

“One of our main goals at Olansky is to be at the forefront of skin cancer treatment,” says Dr. Ilyas, “and Mohs surgery offers a notable improvement to standard therapy.”

ATLANTA (PRWEB)
February 09, 2022

Dr. Humza Ilyas of Olansky Dermatology & Aesthetics – Atlanta’s premier full-service dermatology practice – recently received the prestigious honor of becoming board certified for Mohs surgery. Dr. Ilyas is one of the first Mohs surgeons in the country to achieve this new certification awarded by the American Board of Dermatology.

This outstanding level of recognition not only continues to solidify Dr. Ilyas’ expertise as one of the premier surgeons in this procedure, but it gives patients another reason to choose Olansky Dermatology & Aesthetics with confidence.

“One of our main goals at Olansky is to be at the forefront of skin cancer treatment,” says Dr. Ilyas, “and Mohs surgery offers a notable improvement to standard therapy.”

Mohs surgery is an outpatient procedure that removes skin cancer while minimizing damage to surrounding skin tissue, protecting skin aesthetics. Throughout the surgery, a physician sequentially excises small layers of skin, examining them for the presence of skin cancer. This is done until the skin cancer has been completely extracted. Mohs surgery improves the patient’s chance at a cure and drastically reduces the need for additional treatments, enabling patients to have access to superior treatments with increased accuracy and convenience.

The procedure is regarded as most effective in the treatment of basal cell carcinomas and squamous cell carcinomas, the two most common skin cancer types. The surgery can also be utilized for some melanomas and unusual cancer types.

Dr. Ilyas practices at both Olansky locations in Buckhead and Roswell, offering additional convenience to metro Atlanta patients.

“Mohs surgery can be technically demanding,” Dr. Ilyas explains. “So it’s an honor to be able to share our level of expertise with patients.”

To schedule an appointment with the Mohs surgery experts at Olansky Dermatology & Aesthetics by reaching visit OlanksyDermatology.com or call 404-355-5484.

Olansky Dermatology & Aesthetics is your dermatology solution. Our ability to provide full-service dermatology to patients of all ages is a distinct benefit to choosing our 40-year-old practice. We offer medical, surgical, cosmetic, and aesthetic services to our patients, and even same day appointments when possible. This makes us not only a convenient solution for your family, but a comprehensive one as well. With services ranging from our in-house Mohs surgery for skin cancer, advanced laser therapy for psoriasis or our aesthetic services for skin rejuvenation, Olansky Dermatology & Aesthetics can handle all of your skin concerns. For more details, visit our website at OlanskyDermatology.com or call 404-591-4314.

Interviews are available upon request.

Share article on social media or email:

It is gratifying to see that Constellation Research considers us a next-generation platform to secure the IoT devices that hospitals and their patients depend on as they continue to weather an unprecedented wave of debilitating attacks.

NEW YORK (PRWEB)
February 09, 2022

Cynerio, a leading provider of healthcare IoT cybersecurity, today announced it was named to the Constellation ShortList™ for Healthcare Medical Device Security in Q1 2022. The technology vendors and service providers included in this program deliver critical transformation initiative requirements for early adopter and fast follower organizations.

Cynerio enables hospitals and healthcare facilities to reduce the vulnerability and risk of their IoT, OT and medical devices, and immediately respond to ransomware, breaches and other threats targeting them. The Cynerio Platform goes beyond healthcare IoT asset management to defend devices from active attacks from day one of implementation, while also identifying and remediating the most critical device risks in under a month.

“It is a tremendous honor to be named to the Constellation Shortlist, and a validation of our approach of prioritizing risk reduction and attack mitigation for healthcare IoT,” said Leon Lerman, founder and CEO of Cynerio. “It is gratifying to see that Constellation Research considers us a next-generation platform to secure the IoT devices that hospitals and their patients depend on as they continue to weather an unprecedented wave of debilitating attacks.”

“The Great Refactoring is among us. Organizations must reconsider how they balance business models, work/life priorities, and new market conditions. Our analysts’ recent updates to The ShortList™ reflect the top vendors that matter most to our network of buy side clients,” said R “Ray” Wang, chairman and founder at Constellation Research. “As leaders make the tough decisions in vendor selection, we hope The ShortList™ speed the decision-making process and help buyers find the right partners to enable their business success.”

Constellation Research advises leaders on leveraging disruptive technologies to achieve business model transformation and streamline business processes. Products and services named to the Constellation ShortList meet the threshold criteria for this category as determined through client inquiries, partner conversations, customer references, vendor selection projects, market share and internal research. The portfolio is updated at least once per year as the analyst team deems necessary based on market conditions.

For more information, visit Cynerio.com.

About Cynerio

Cynerio is the one-stop shop Healthcare IoT security platform. With solutions that cater to healthcare’s every IoT need – from Enterprise IoT to OT and IoMT – we promote cross-organizational alignment and provide hospitals the control, foresight, and adaptability they require to stay cyber-secure in a constantly evolving threatscape. We empower healthcare organizations to stay compliant and proactively manage every connection on their own terms with real-time IoT attack detection and response and rapid risk reduction tools, so that they can focus on healthcare’s top priority: delivering quality patient care. For more information, visit http://www.cynerio.com and follow the company on LinkedIn and Twitter.

Disclaimer

Constellation Research does not endorse any solution or service named in its research.

Share article on social media or email:

The partnership with Smile Brands will allow us to expand our hygiene and perio care while maintaining our current culture.

IRVINE, Calif. (PRWEB)
February 09, 2022

Smile Brands, one of the nation’s leading dental support organizations (DSO), is pleased to announce its new affiliate partnership with G’s Dental Studio in Cedar Park and Leander, TX.

Dr. Aleksandar Gavrilov and Hristina Kiprovska-Gavrilov founded G’s Dental Studio in Cedar Park in 2011 with the goal of helping patients of all ages enjoy the benefits of a healthy, beautiful smile. They opened the Leander location in 2016 to expand their patient reach in the area and currently lead a team of 14 across both locations. Together, the teams deliver general dentistry, preventive and restorative care, specialty care, cosmetic dentistry, and emergency services.

Having worked at a Castle Dental years ago, Dr. Alex Gavrilov was familiar with the Smile Brands’ culture and operational support. “When we were looking to affiliate with a DSO, Smile Brands was a clear choice,” said Dr. Gavrilov. “The partnership with Smile Brands will allow us to expand our hygiene and perio care while maintaining our current culture,” said Dr. Gavrilov.

Smile Brands will provide administrative support and services to the practices including purchasing, payroll, accounting, IT, billing, facilities management, and marketing. The businesses will continue to operate under the G’s Dental Studio name and the existing staff will remain with the offices.

“We are thrilled to welcome back Dr. Alex Gavrilov and partner with Dr. Hristina Kiprovska-Gavrilov, and their teams,” said Steve Bilt, Smile Brands co-founder, and CEO. “We look forward to helping G’s Dental Studio improve their purchasing power and streamline administration in 2022.”

About Smile Brands:

Smile Brands, based in Irvine, California, is one of the largest providers of dental support services in the United States. The company supports nearly 700 affiliated practices, with more than 7,500 dedicated team members across 30 states. Smile Brands supports a portfolio of over 75 brands including well-known regional brands: Bright Now! Dental, Castle Dental, Merit Dental, Midwest Dental, Monarch Dental, and Mondovi Dental. The company provides comprehensive business support services through exclusive long-term agreements with affiliate dental groups, allowing affiliated practices to spend more time caring for patients and less time on the administrative, marketing, and financial aspects of operating a dental office. The organization receives frequent recognition for its award-winning culture and has been recognized as a Best Place to Work by Glassdoor, Comparably, Stevie® Awards, and more. Smile Brands is a portfolio company of Gryphon Investors, a leading middle-market private equity firm based in San Francisco, CA. Visit smilebrands.com for more information.

Share article on social media or email:

Grin Oral Care

“We know that we can’t save the world alone, but we are working hard to develop oral care products that are simply better for the environment and for the people who use them.”

SAN DIEGO (PRWEB)
February 09, 2022

Grin Oral Care has entered the United States oral care market by storm. Grin Oral Care’s products can be found in more than 25 retailers in the United States and in more than 5 countries around the globe.

According to Grin Oral Care’s management, Grin Oral Care lives by the mantra… Earth Lovin’! “We know that we can’t save the world alone, but we are working hard to develop oral care products that are simply better for the environment and for the people who use them”. Grin Oral Care has designed and developed a range of “clinically better”, innovative, patented and patent pending products to meet consumer’s needs. Grin Oral Care is a total oral care solutions company with more than 20 different product offerings.

Grin Oral Care’s goal is to simplify the shopping experience with bold, easy to understand contemporary packaging that appeals to everyone and to disrupt an otherwise sleepy oral care category. Grin Oral Care is looking forward in 2022 to expanding its distribution in more U.S. retailers, launching its dental professional program and growing its global foot print.

Grin Oral Care’s focus on “clinically better and simply better for you” products will continue to drive the brand now and into the future. Look out for Grin Oral Care products and follow @GrinOralCare on Instagram and Facebook. See the line at http://www.grinoralcare.com.

Share article on social media or email:

Margaret Larkins-Pettigrew, MD, Med, MPPM, FACOG, Senior Vice President and Chief Clinical Officer of Diversity, Equity and Inclusion for AHN/Highmark Health.

“We’re ‘thinking outside the box’ and bringing the vaccine into local communities, in convenient locations hosted by trusted local business leaders” – Margaret Larkins-Pettigrew, MD

PITTSBURGH (PRWEB)
February 09, 2022

Allegheny Health Network (AHN), as part of its commitment to ensuring all communities have equal access to the COVID-19 vaccine, and in partnership with the TRAC Services for Families, is launching “Power Hour and Cut to the Chase” – a series of community-based clinics set in hair salons, bars, restaurants and other community gathering places where vaccines, including booster shots, will be available to anyone attending.

The “Power Hour and Cut to the Chase” vaccination campaign, staffed by AHN clinicians, launches Thursday, Feb. 10 from noon to 3 p.m. at Elevationz hair salon on Second Avenue in Hazelwood, followed by Friday, Feb. 11 from 4-8 p.m. at Young Bros. bar on Pittsburgh’s North Side; and Saturday, Feb. 12 from 2- 4 p.m. at Vickey’s Soul Grill, 655 Rodi Rd. in Penn Hills. Incentives, including gift cards, will be offered, to anyone getting a vaccine.

“The recent surge in Omicron cases has shown us that the COVID-19 pandemic is not over and vaccination remains the single most important weapon we have against this dangerous virus,” said Margaret Larkins-Pettigrew, MD, Med, MPPM, FACOG, Senior Vice President and Chief Clinical Officer of Diversity, Equity and Inclusion for AHN/Highmark Health. “We know that many people face barriers to vaccination such as a lack of transportation or access to accurate information about the vaccine.

“That’s why we’re ‘thinking outside the box’ and bringing the vaccine into local communities, in convenient locations hosted by trusted local business leaders,” Dr. Larkins-Pettigrew said. “We hope that residents of these communities take advantage of our clinics, which are open to anyone. If you want a vaccine or a booster, you are welcome. Insurance is not required, and you do not need to be an AHN patient.”

Additional dates and times set for “Power Hour and Cut to the Chase” vaccine clinics include:

Feb. 16, 1-3 p.m, TrZade, 113 Brownsville Road, Mount Oliver

Feb. 17, 5-7 p.m., Stanley’s Lounge, 7403 Frankstown Ave., Homewood

Feb. 18, noon-3 p.m., B-Sharp, 10720 Frankstown Rd., Penn Hills

Feb. 20, 2-4 p.m. Carmi Restaurant, 1825 E. Carson St., South Side

Feb. 21, 1-3 p.m., Club Mansion, 7232 Kelly St., Homewood

Feb. 25, 4-6 p.m., Lounge 7101, 7101 Frankstown Ave., Homewood

Feb. 26, 1-3 p.m., VIP Styles, 413, Smithfield St., downtown Pittsburgh

Feb. 27, 1-4 p.m., Dreamz, 216 E. 7th Ave., Homestead

Feb. 28, 1-4 p.m., TBJ’s Soul Food, 313 Franklin Ave., Aliquippa

March 4, noon-2 p.m., Dave’s Barber Shop, 1811 Brighton Place, North Side

March 5, PURO Cigar Lounge, 508 Grant Ave., Duquesne

March 6, 1-3 p.m., Brother’s Keeper, 613 E. Ohio St., North Side

Announcements of additional clinics are expected to be made in the coming weeks.

About the Allegheny Health Network:

Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 12 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,500 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine, Temple University School of Medicine, and the Lake Erie College of Osteopathic Medicine.

About TRAC Services for Families

TRAC Services for Families is a non-profit agency providing foster care, adoption and outpatient mental health services to children and adults. TRAC has a strong commitment to “moving the needle” on increasing vaccinations particularly in communities of color.

Join this insightful webinar to also hear about a critical new finding which the featured speakers believe will be of value to the audience, including clinicians caring for patients with HFpEF and scientists seeking new avenues for investigation and identification of this patient cohort.

TORONTO (PRWEB)
February 09, 2022

Heart failure (HF) can be defined as a clinical syndrome due to structural and/or functional cardiac abnormalities, which results in reduced cardiac output. Identified factors have been associated with risk of progressive HF death and hospitalization in patients with heart failure with preserved ejection fraction (HFpEF) compared to patients with heart failure with reduced ejection fraction (HFrEF).

In this webinar, the featured speakers will discuss the prospective cohort study which followed up with over 900 patients identified as having HFrEF or HFpEF using the European Society of Cardiology guidelines for over five years (4,481 patient-years of follow-up). The primary aim was to examine risk markers for progressive heart failure in patients with HFrEF or HFpEF.

Targeted treatments for HFpEF are lacking, partly due to a substantial gap in the understanding of the mechanisms underpinning the pathophysiology of HFpEF. Hospitalizations or deaths of patients were characterized in relation to HFpEF and HFrEF due to progressive heart failure.

Please join this insightful webinar to also hear about a critical new finding which the featured speakers believe will be of value to the audience, including clinicians caring for patients with HFpEF and scientists seeking new avenues for investigation and identification of this patient cohort.

Join Prof. Mark Kearney, Executive Dean of the Faculty of Medicine and Health, University of Leeds; and Dr. Elias Ketiar MD, DM MRCP, Sr. Medical Director Therapeutic Area Strategy, AES, for the live webinar on Wednesday, March 2, 2022 at 10am EST (3pm GMT/UK).

For more information, or to register for this event, visit Heart Failure with Preserved Ejection Fraction (HFpEF) — Clues to the Identification of Undiagnosed Patients.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: